• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

南非初级保健机构实施结核病预防策略的卫生系统障碍。

Health system barriers to implementation of TB preventive strategies in South African primary care facilities.

机构信息

Witkoppen Health and Welfare Centre, Johannesburg, South Africa.

Department of Epidemiology and Social Medicine (ESOC), University of Antwerp, Antwerp, Belgium.

出版信息

PLoS One. 2019 Feb 14;14(2):e0212035. doi: 10.1371/journal.pone.0212035. eCollection 2019.

DOI:10.1371/journal.pone.0212035
PMID:30763378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6375590/
Abstract

BACKGROUND

Isoniazid preventive therapy (IPT) is a key component of TB/HIV control, but few countries achieve high IPT coverage.

METHODS

Using a behavioural COM-B design approach, the intervention consisted of a training on IPT guidelines and tuberculin skin testing (TST), identification of the optimal IPT implementation strategy by the health care workers (HCWs) of 3 primary care clinics, and a 2-month mentoring period. Using routine register data, TST and IPT uptake was determined 3 months before and 5 months after the intervention. Records were reviewed to identify factors associated with IPT initiation and HCW fidelity to the guidelines. A survey among HCWs was conducted to determine barriers to IPT.

RESULTS

Two clinics implemented TST-guided IPT for all clients receiving HIV care, one clinic decided against use of TST. According to routine register data, the proportion of clients initiating IPT increased substantially at the clinic not opting for TST (6% vs 36%), but minimally (34% vs 37% and 0.7% vs 3%) in the two other clinics. TST uptake did not increase (0 vs 0% and 0.5%). In addition to poor IPT uptake, HCW fidelity to investigation for TB and timing of IPT initiation was poor, with only 68% of symptomatic patients investigated and IPT initiation delayed to a median of 374 days post-ART initiation. In multivariate analysis, pregnancy (aOR 18.62, 95% CI 6.99-53.46), recent HIV diagnosis (aOR 3.65, 95% CI 1.73-7.41), being on ART (aOR 9.44, 95% CI 3.05-36.17), and CD4 <500 cells/mm3 (aOR 2.19, 95% CI 1.22-4.18) were associated with IPT initiation. Time needed to perform a TST, motivating patients to return for TST reading, and low IPT patient awareness were the main barriers to IPT implementation.

CONCLUSION

Despite using a behavioural intervention framework including training and participatory development of the clinic IPT strategy, HCW fidelity to the guidelines was poor, resulting in low TST coverage and low IPT uptake under primary care conditions. To achieve the benefits of IPT, health system level approaches including TST-free guidelines and sensitization are needed.

摘要

背景

异烟肼预防治疗(IPT)是结核病/艾滋病控制的一个重要组成部分,但很少有国家能达到高IPT 覆盖率。

方法

采用行为 COM-B 设计方法,该干预措施包括IPT 指南和结核菌素皮肤试验(TST)培训、3 家初级保健诊所的卫生保健工作者确定最佳 IPT 实施策略,以及为期 2 个月的指导期。使用常规登记数据,在干预前 3 个月和干预后 5 个月确定 TST 和 IPT 的采用情况。对记录进行审查,以确定与 IPT 开始相关的因素和 HCW 对指南的遵从性。对 HCW 进行了一项调查,以确定IPT 的障碍。

结果

两家诊所对所有接受艾滋病毒护理的患者实施了 TST 指导的 IPT,一家诊所决定不使用 TST。根据常规登记数据,在不选择 TST 的诊所,开始 IPT 的患者比例大幅增加(6%对 36%),而在另外两家诊所则略有增加(34%对 37%和 0.7%对 3%)。TST 的采用率没有增加(0 对 0%和 0.5%)。除了 IPT 采用率低外,HCW 对结核病调查和 IPT 开始时间的遵从性也很差,只有 68%的有症状患者接受了调查,IPT 的开始时间延迟到抗逆转录病毒治疗(ART)开始后中位数 374 天。在多变量分析中,妊娠(优势比 18.62,95%置信区间 6.99-53.46)、近期 HIV 诊断(优势比 3.65,95%置信区间 1.73-7.41)、正在接受 ART(优势比 9.44,95%置信区间 3.05-36.17)和 CD4<500 个细胞/mm3(优势比 2.19,95%置信区间 1.22-4.18)与 IPT 的开始相关。进行 TST 所需的时间、激励患者返回进行 TST 阅读,以及 IPT 患者意识低是 IPT 实施的主要障碍。

结论

尽管采用了包括培训和参与制定诊所 IPT 策略的行为干预框架,但 HCW 对指南的遵从性很差,导致 TST 覆盖率低,初级保健条件下 IPT 采用率低。要实现 IPT 的益处,需要采取包括无 TST 指南和宣传在内的卫生系统层面的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4a9/6375590/3fe3b6818bbe/pone.0212035.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4a9/6375590/3fe3b6818bbe/pone.0212035.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4a9/6375590/3fe3b6818bbe/pone.0212035.g001.jpg

相似文献

1
Health system barriers to implementation of TB preventive strategies in South African primary care facilities.南非初级保健机构实施结核病预防策略的卫生系统障碍。
PLoS One. 2019 Feb 14;14(2):e0212035. doi: 10.1371/journal.pone.0212035. eCollection 2019.
2
Implementation and Operational Research: Feasibility of Using Tuberculin Skin Test Screening for Initiation of 36-Month Isoniazid Preventive Therapy in HIV-Infected Patients in Resource-Constrained Settings.实施与运营研究:在资源有限的环境中,对感染艾滋病毒的患者采用结核菌素皮肤试验筛查以启动36个月异烟肼预防性治疗的可行性。
J Acquir Immune Defic Syndr. 2016 Apr 1;71(4):e89-95. doi: 10.1097/QAI.0000000000000895.
3
Systematic review of TST responses in people living with HIV in under-resourced settings: implications for isoniazid preventive therapy.资源匮乏环境下 HIV 感染者结核菌素皮肤试验反应的系统评价:异烟肼预防治疗的意义。
PLoS One. 2012;7(11):e49928. doi: 10.1371/journal.pone.0049928. Epub 2012 Nov 27.
4
Contact evaluation and isoniazid preventive therapy among close and household contacts of tuberculosis patients in Lima, Peru: an analysis of routine data.秘鲁利马结核患者的密切接触者和家庭成员的接触评估和异烟肼预防治疗:常规数据分析。
Trop Med Int Health. 2020 Mar;25(3):346-356. doi: 10.1111/tmi.13350. Epub 2019 Dec 12.
5
CD4+ cell count stratification to guide tuberculosis preventive therapy for people living with HIV.根据 CD4+ 细胞计数分层,指导 HIV 感染者进行结核分枝杆菌预防性治疗。
AIDS. 2020 Jan 1;34(1):139-147. doi: 10.1097/QAD.0000000000002398.
6
Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania.坦桑尼亚 HIV 感染、TST 阳性成人中异烟肼预防治疗的完成情况与生存。
Int J Tuberc Lung Dis. 2011 Nov;15(11):1515-21, i. doi: 10.5588/ijtld.10.0788.
7
Coverage of isoniazid preventive therapy among people living with HIV; A retrospective cohort study in Tanzania (2012-2016).HIV 感染者中异烟肼预防性治疗的覆盖情况;坦桑尼亚的一项回顾性队列研究(2012-2016 年)。
Int J Infect Dis. 2021 Feb;103:562-567. doi: 10.1016/j.ijid.2020.11.192. Epub 2020 Dec 2.
8
Cost-effectiveness of universal isoniazid preventive therapy among HIV-infected pregnant women in South Africa.南非感染 HIV 的孕妇中普遍使用异烟肼预防治疗的成本效益。
Int J Tuberc Lung Dis. 2018 Dec 1;22(12):1435-1442. doi: 10.5588/ijtld.18.0370.
9
Household point of care CD4 testing and isoniazid preventive therapy initiation in a household TB contact tracing programme in two districts of South Africa.南非两个地区家庭为基础的护理点 CD4 检测和异烟肼预防治疗启动在家庭结核接触者追踪规划中的应用。
PLoS One. 2018 Mar 2;13(3):e0192089. doi: 10.1371/journal.pone.0192089. eCollection 2018.
10
Tuberculin skin test reversion following isoniazid preventive therapy reflects diversity of immune response to primary Mycobacterium tuberculosis infection.异烟肼预防性治疗后结核菌素皮肤试验结果逆转反映了对原发性结核分枝杆菌感染免疫反应的多样性。
PLoS One. 2014 May 5;9(5):e96613. doi: 10.1371/journal.pone.0096613. eCollection 2014.

引用本文的文献

1
Effectiveness of tuberculosis preventive treatment on disease incidence among people living with HIV/AIDS: A systematic review and meta-analysis.结核病预防性治疗对艾滋病毒/艾滋病感染者疾病发病率的有效性:一项系统评价和荟萃分析。
PLoS One. 2025 Aug 26;20(8):e0330208. doi: 10.1371/journal.pone.0330208. eCollection 2025.
2
An evaluation of a choice architecture-based intervention on prescribing of TB preventive treatment to people living with HIV in southern Africa (the CAT study): a cluster-randomised trial.一项基于选择架构的干预措施对非洲南部艾滋病毒感染者结核病预防性治疗处方影响的评估(CAT研究):一项整群随机试验。
BMJ Glob Health. 2025 May 24;10(5):e016921. doi: 10.1136/bmjgh-2024-016921.
3

本文引用的文献

1
Barriers in the implementation of isoniazid preventive therapy for people living with HIV in Northern Ethiopia: a mixed quantitative and qualitative study.埃塞俄比亚北部为艾滋病毒感染者实施异烟肼预防性治疗的障碍:一项定量与定性相结合的研究
BMC Public Health. 2016 Aug 19;16(1):840. doi: 10.1186/s12889-016-3525-8.
2
Implementation and Operational Research: Feasibility of Using Tuberculin Skin Test Screening for Initiation of 36-Month Isoniazid Preventive Therapy in HIV-Infected Patients in Resource-Constrained Settings.实施与运营研究:在资源有限的环境中,对感染艾滋病毒的患者采用结核菌素皮肤试验筛查以启动36个月异烟肼预防性治疗的可行性。
J Acquir Immune Defic Syndr. 2016 Apr 1;71(4):e89-95. doi: 10.1097/QAI.0000000000000895.
3
Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art Review.
高结核病负担地区的结核病预防性治疗:最新综述
Drugs. 2025 Feb;85(2):127-147. doi: 10.1007/s40265-024-02131-3. Epub 2024 Dec 28.
4
"Sometimes it can be like an icebreaker": A mixed method evaluation of the implementation of the Refugee Health Screener-13 (RHS-13).“有时它就像一个打破僵局的工具”:对难民健康筛查器13(RHS - 13)实施情况的混合方法评估
J Migr Health. 2024 Jul 15;10:100243. doi: 10.1016/j.jmh.2024.100243. eCollection 2024.
5
Facilitators and barriers to initiating and completing tuberculosis preventive treatment among children and adolescents living with HIV in Uganda: a qualitative study of adolescents, caretakers and health workers.乌干达艾滋病毒感染者儿童和青少年启动和完成结核病预防治疗的促进因素和障碍:青少年、照顾者和卫生工作者的定性研究。
AIDS Res Ther. 2024 Aug 29;21(1):59. doi: 10.1186/s12981-024-00643-2.
6
Sustainable solutions to barriers of point-of-care diagnostic testing services in health facilities without laboratories in the bono region, Ghana: a qualitative study.在加纳博诺地区没有实验室的卫生设施中提供即时诊断检测服务的可持续解决方案:一项定性研究。
BMC Prim Care. 2024 May 22;25(1):179. doi: 10.1186/s12875-024-02406-4.
7
Do community-based active case-finding interventions have indirect impacts on wider TB case detection and determinants of subsequent TB testing behaviour? A systematic review.基于社区的主动病例发现干预措施对更广泛的结核病病例发现及后续结核病检测行为的决定因素是否有间接影响?一项系统综述。
PLOS Glob Public Health. 2021 Dec 8;1(12):e0000088. doi: 10.1371/journal.pgph.0000088. eCollection 2021.
8
Facilitators and barriers to in vitro diagnostics implementation in resource-limited settings: A scoping review.资源有限环境下体外诊断实施的促进因素和障碍:范围综述。
Afr J Prim Health Care Fam Med. 2023 Feb 3;15(1):e1-e9. doi: 10.4102/phcfm.v15i1.3777.
9
Reasons for poor uptake of TB preventive therapy in South Africa.南非结核病预防性治疗使用率低的原因。
Public Health Action. 2022 Dec 21;12(4):159-164. doi: 10.5588/pha.22.0030.
10
Drop-offs in the isoniazid preventive therapy cascade among children living with HIV in western Kenya, 2015-2019.2015-2019 年肯尼亚西部儿童艾滋病毒感染者中异烟肼预防性治疗级联中的脱落现象。
J Int AIDS Soc. 2022 Aug;25(8):e25939. doi: 10.1002/jia2.25939.
Tuberculosis preventive therapy: an underutilised strategy to reduce individual risk of TB and contribute to TB control.
结核病预防性治疗:一种未得到充分利用的策略,可降低个体患结核病的风险并促进结核病控制。
S Afr Med J. 2014 Apr 16;104(5):339-43. doi: 10.7196/samj.8290.
4
Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial.异烟肼联合抗逆转录病毒疗法预防结核病:一项随机、双盲、安慰剂对照试验。
Lancet. 2014 Aug 23;384(9944):682-90. doi: 10.1016/S0140-6736(14)60162-8. Epub 2014 May 13.
5
Survey of isoniazid preventive therapy in South Africa, 2011.2011 年南非异烟肼预防治疗调查。
Int J Tuberc Lung Dis. 2012 Jul;16(7):903-7. doi: 10.5588/ijtld.11.0722. Epub 2012 May 7.
6
The behaviour change wheel: a new method for characterising and designing behaviour change interventions.行为改变轮:一种描述和设计行为改变干预措施的新方法。
Implement Sci. 2011 Apr 23;6:42. doi: 10.1186/1748-5908-6-42.
7
6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial.6 个月与 36 个月异烟肼预防治疗成人 HIV 感染者结核病:博茨瓦纳的一项随机、双盲、安慰剂对照试验。
Lancet. 2011 May 7;377(9777):1588-98. doi: 10.1016/S0140-6736(11)60204-3. Epub 2011 Apr 12.
8
Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study.在 HIV 诊所中实施异烟肼预防治疗的障碍:一项定性研究。
AIDS. 2010 Nov;24 Suppl 5:S45-8. doi: 10.1097/01.aids.0000391021.18284.12.
9
Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies.抗反转录病毒治疗患者中的结核病:发病率、危险因素和预防策略。
J Acquir Immune Defic Syndr. 2011 Apr;56(4):349-55. doi: 10.1097/QAI.0b013e3181f9fb39.
10
Training health care workers to promote HIV services for patients with tuberculosis in the Democratic Republic of Congo.培训卫生保健工作者,以在刚果民主共和国为结核病患者提供艾滋病毒服务。
Hum Resour Health. 2009 Mar 17;7:23. doi: 10.1186/1478-4491-7-23.